Ultrasonic therapy for gynecologic tumors

Area of Science:

• Oncology
• Medical Physics
• Gynecology

Background:

• Gynecologic tumors pose significant health challenges.
• Current treatments have limitations and side effects.
• Noninvasive therapeutic modalities are highly sought after.

Purpose of the Study:

• To review the clinical and potential applications of ultrasonic therapy for gynecologic tumors.
• To highlight the mechanisms and efficacy of high-intensity focused ultrasound (HIFU).
• To explore ultrasound's role in enhancing chemotherapy and hyperthermia for gynecologic cancers.

Main Methods:

• Review of clinical data and preclinical trials on ultrasonic therapy for gynecologic tumors.
• Extracorporeal high-intensity focused ultrasound (HIFU) for uterine myomas.
• Ultrasound-enhanced chemotherapy and hyperthermia for ovarian and cervical cancers.
• Transvaginal ultrasonic therapy for cervical lesions.

Main Results:

• HIFU effectively treats uterine fibroids by shrinking tumors, reducing blood supply, and suppressing proliferation, improving symptoms and quality of life.
• Preclinical studies show ultrasound enhances cytotoxic agents, overcoming resistance in ovarian cancers (doxorubicin, cisplatin).
• Ultrasonic hyperthermia shows potential for cervical cancer treatment by increasing temperature in deep tumor tissues.

Conclusions:

• Ultrasonic therapy is a promising, noninvasive treatment modality for various gynecologic tumors.
• HIFU offers a viable option for uterine fibroids and potentially other gynecologic malignancies.
• Ultrasound-based therapies may overcome chemoresistance and enhance treatment efficacy, potentially changing clinical practices.